[go: up one dir, main page]

Newburg et al., 2005 - Google Patents

Human milk glycans protect infants against enteric pathogens

Newburg et al., 2005

View PDF
Document ID
7337961393635149151
Author
Newburg D
Ruiz-Palacios G
Morrow A
Publication year
Publication venue
Annu. Rev. Nutr.

External Links

Snippet

▪ Abstract Breastfed infants have lower morbidity and mortality due to diarrhea than those fed artificially. This had been attributed primarily to the secretory antibodies and prebiotic factors in human milk. Oligosaccharides are the third largest component of human milk. They were …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Similar Documents

Publication Publication Date Title
Newburg et al. Human milk glycans protect infants against enteric pathogens
Newburg Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans
Wiciński et al. Human milk oligosaccharides: health benefits, potential applications in infant formulas, and pharmacology
Zhang et al. Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota
Dinleyici et al. Functional effects of human milk oligosaccharides (HMOs)
EP1689348B1 (en) Oligosaccharide compositions and use thereof in the treatment of infection
Triantis et al. Immunological effects of human milk oligosaccharides
Newburg Oligosaccharides and glycoconjugates in human milk: their role in host defense
Bode The functional biology of human milk oligosaccharides
Ulfman et al. Effects of bovine immunoglobulins on immune function, allergy, and infection
Newburg Human milk glycoconjugates that inhibit pathogens
Morrow et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants
Ruiz-Palacios et al. Campylobacter jejuni binds intestinal H (O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection
Hickey The role of oligosaccharides from human milk and other sources in prevention of pathogen adhesion
Turin et al. The role of maternal breast milk in preventing infantile diarrhea in the developing world
Coppa et al. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris
CN103442696B (en) Prevention or two sialic acid LNT (oligosaccharide). (DSLNT) or its variant, isomer, sum analogous to general Dedekind sum of suppression enteropathy
OPEKUN et al. Novel therapies for Helicobacter pylori infection
CN105007924B (en) Synthesis or recombination fucosylation oligosaccharide for being applied in treatment infection
WO1994009651A1 (en) Anti-diarrheic product and method of treating rotavirus-associated infection
Sekerel et al. An expert panel statement on the beneficial effects of human milk oligosaccharides (HMOs) in early life and potential utility of HMO-supplemented infant formula in cow’s milk protein allergy
Wang et al. Current advances in structure–function relationships and dose-dependent effects of human milk oligosaccharides
Yang et al. Protection from viral infections by human milk oligosaccharides: direct blockade and indirect modulation of intestinal ecology and immune reactions
Duman et al. Human milk oligosaccharides: decoding their structural variability, health benefits, and the evolution of infant nutrition
CA2441696C (en) Formulation to treat or prevent parasitic infection